{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:53:11Z","timestamp":1769010791341,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91405-1","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T05:53:04Z","timestamp":1743054784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of axillary lymph node dissection on the prognosis of breast cancer patients undergoing up-front mastectomy with Sentinel lymph node micrometastases"],"prefix":"10.1038","volume":"15","author":[{"given":"Wu","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YongTian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"6773","key":"91405_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/bmj.302.6773.360","volume":"302","author":"PJ O\u2019Dwyer","year":"1991","unstructured":"O\u2019Dwyer, P. J. Axillary dissection in primary breast cancer. BMJ 302(6773), 360\u2013361 (1991).","journal-title":"BMJ"},{"issue":"1","key":"91405_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jso.2930500114","volume":"50","author":"M Hladiuk","year":"1992","unstructured":"Hladiuk, M. et al. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J. Surg. Oncol. 50(1), 47\u201352 (1992).","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"91405_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/bjc.1992.230","volume":"66","author":"D Ivens","year":"1992","unstructured":"Ivens, D. et al. Assessment of morbidity from complete axillary dissection. Br. J. Cancer. 66(1), 136\u2013138 (1992).","journal-title":"Br. J. Cancer"},{"issue":"6","key":"91405_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano, A. E. et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and Sentinel node metastasis: a randomized clinical trial. JAMA 305(6), 569\u2013575 (2011).","journal-title":"JAMA"},{"issue":"10","key":"91405_CR5","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti, V. et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 19(10), 1385\u20131393 (2018).","journal-title":"Lancet Oncol."},{"issue":"12","key":"91405_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker, M. et al. Radiotherapy or surgery of the axilla after a positive Sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 15(12), 1303\u20131310 (2014).","journal-title":"Lancet Oncol."},{"issue":"6","key":"91405_CR7","doi-asserted-by":"publisher","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","volume":"21","author":"WJ Gradishar","year":"2023","unstructured":"Gradishar, W. J. et al. NCCN guidelines insights: breast cancer, version 4.2023. J. Natl. Compr. Canc Netw. 21(6), 594\u2013608 (2023).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"91405_CR8","unstructured":"Amin, M. B. et al. (eds) American Joint Committee on Cancer Staging Manual 8th edn (Springer, 2017)."},{"issue":"13","key":"91405_CR9","doi-asserted-by":"publisher","first-page":"8717","DOI":"10.1245\/s10434-021-10374-7","volume":"28","author":"R Weiser","year":"2021","unstructured":"Weiser, R. et al. Prognosis and chemotherapy use in breast cancer patients with multiple lymphatic micrometastases: an NCDB analysis. Ann. Surg. Oncol. 28(13), 8717\u20138727 (2021).","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"91405_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10549-020-05971-1","volume":"185","author":"R Weiser","year":"2021","unstructured":"Weiser, R. et al. The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary Tale from an NCDB analysis. Breast Cancer Res. Treat. 185(3), 667\u2013676 (2021).","journal-title":"Breast Cancer Res. Treat."},{"key":"91405_CR11","doi-asserted-by":"publisher","first-page":"596545","DOI":"10.3389\/fonc.2020.596545","volume":"10","author":"SP Luo","year":"2021","unstructured":"Luo, S. P. et al. Association of axillary lymph node evaluation with survival in women aged 70 years or older with breast cancer. Front. Oncol. 10, 596545 (2021).","journal-title":"Front. Oncol."},{"issue":"24","key":"91405_CR12","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci, A. et al. Surgical complications associated with Sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011. J. Clin. Oncol. 25(24), 3657\u20133663 (2007).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"91405_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.breast.2007.08.006","volume":"17","author":"A Husted Madsen","year":"2008","unstructured":"Husted Madsen, A. et al. Arm morbidity following Sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish breast Cancer cooperative group. Breast 17(2), 138\u2013147 (2008).","journal-title":"Breast"},{"issue":"5","key":"91405_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejso.2007.05.017","volume":"34","author":"P Del Bianco","year":"2008","unstructured":"Del Bianco, P. et al. Morbidity comparison of Sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the Sentinella-GIVOM Italian randomised clinical trial. Eur. J. Surg. Oncol. 34(5), 508\u2013513 (2008).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"91405_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","volume":"2","author":"DN Krag","year":"1993","unstructured":"Krag, D. N. et al. Surgical resection and radiolocalization of the Sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 2(6), 335\u2013339 (1993). discussion 340.","journal-title":"Surg. Oncol."},{"key":"91405_CR16","doi-asserted-by":"crossref","unstructured":"Giuliano, A. E. et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg.  220(3), 391\u2013398 (1994).","DOI":"10.1097\/00000658-199409000-00015"},{"key":"91405_CR17","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.2147\/CMAR.S192573","volume":"11","author":"BB Cong","year":"2019","unstructured":"Cong, B. B., Yu, J. M. & Wang, Y. S. Axillary management still needed for patients with Sentinel node micrometastases. Cancer Manag Res. 11, 2097\u20132100 (2019).","journal-title":"Cancer Manag Res."},{"issue":"15","key":"91405_CR18","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.ejca.2008.06.033","volume":"44","author":"G Cserni","year":"2008","unstructured":"Cserni, G. et al. Variations in Sentinel node isolated tumour cells\/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur. J. Cancer. 44(15), 2185\u20132191 (2008).","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"91405_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5306\/wjco.v7.i2.243","volume":"7","author":"A Tallet","year":"2016","unstructured":"Tallet, A. et al. Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on Sentinel lymph node biopsy. World J. Clin. Oncol. 7(2), 243\u2013252 (2016).","journal-title":"World J. Clin. Oncol."},{"issue":"5","key":"91405_CR20","first-page":"371","volume":"28","author":"ML Pilewskie","year":"2014","unstructured":"Pilewskie, M. L. & Morrow, M. Management of the clinically nodenegative axilla: what have we learned from the clinical trials? Oncol. (Williston Park). 28(5), 371\u2013378 (2014).","journal-title":"Oncol. (Williston Park)"},{"issue":"6","key":"91405_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi, U. et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl. J. Med. 349(6), 546\u2013553 (2003).","journal-title":"N Engl. J. Med."},{"issue":"3","key":"91405_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano, A. E. et al. Locoregional recurrence after Sentinel lymph node dissection with or without axillary dissection in patients with Sentinel lymph node metastases: the American college of surgeons oncology group Z0011 randomized trial. Ann. Surg. 264(3), 413\u2013420 (2016).","journal-title":"Ann. Surg."},{"issue":"1","key":"91405_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sola","year":"2013","unstructured":"Sola, M. et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with Sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann. Surg. Oncol. 20(1), 120\u2013127 (2013).","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"91405_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.yasu.2017.03.013","volume":"51","author":"LC Ozcan","year":"2017","unstructured":"Ozcan, L. C. & Giuliano, A. E. Is axillary lymph node dissection necessary after a positive Sentinel lymph node biopsy?? Adv. Surg. 51(1), 165\u2013178 (2017).","journal-title":"Adv. Surg."},{"issue":"8","key":"91405_CR25","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1245\/s10434-017-5866-7","volume":"24","author":"A Mamtani","year":"2017","unstructured":"Mamtani, A. et al. Axillary micrometastases and isolated tumor cells are not an indication for Post-Mastectomy radiotherapy in stage 1 and 2 breast Cancer. Ann. Surg. Oncol. 24(8), 2182\u20132188 (2017).","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"91405_CR26","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1245\/s10434-020-08225-y","volume":"27","author":"M Castelo","year":"2020","unstructured":"Castelo, M. et al. Comparing observation, axillary radiotherapy, and completion axillary lymph node dissection for management of axilla in breast Cancer in patients with positive Sentinel nodes: A systematic review. Ann. Surg. Oncol. 27(8), 2664\u20132676 (2020).","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"91405_CR27","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/cancers16061198","volume":"16","author":"C Nicolas","year":"2024","unstructured":"Nicolas, C. et al. Does breast surgery type alter incidental axillary irradiation?? A dosimetric analysis of the Sentinel Envahi et randomisation du curage SERC trial. Cancers (Basel). 16(6), 1198 (2024).","journal-title":"Cancers (Basel)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91405-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91405-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91405-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T08:48:38Z","timestamp":1744793318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91405-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91405"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91405-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article Wu Ding and YongTian Chen were omitted as equally contributing authors. The statement has now been added and reads: \u201cWu Ding and YongTian Chen contributed equally to this work.\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Our study was approved by the independent ethics committee\/institutional review board at Shaoxing Second Hospital Ethical Committee. The data from the SEER datasets are publicly available and therefore do not require informed patient consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"10525"}}